Doctor: I Can Synthesize Infinite Entries

Chapter 342: Chapter 232: Mutual Destruction? Wu Ting Becomes the 2nd-Largest Shareholder!

Xianglin City Xuanshang University Affiliated Tumor Hospital.

Vice Dean Chen Bofeng gathered all the doctors from the Hepatic Tumor Surgery department. In addition, he invited chief physicians from affiliated and subordinate hospitals to observe and learn.

Chen Bofeng had scheduled a special surgery for today—the debut of Wu Ting’s Perfect Triple Method, an auxiliary technique he had been eagerly anticipating.

Chen Bofeng himself would be the lead surgeon, assisted by a team of three doctors who had undergone systematic training at Fan City First Hospital.

For this surgery, the City First Hospital Research Center had also dispatched Yan Xi to act as an instructor, guiding and supporting the first independent implementation of this auxiliary technique at the tumor hospital.

This was the business model Wu Ting and Deng Feifei had agreed upon. In addition to selling the system’s equipment, the City First Hospital Research Center would also coordinate doctor training and subsequent technical support.

The deal would only be officially finalized after the buyer’s team had fully mastered the entire surgical procedure.

The surgery began. The 3D imaging and navigation application platform had been upgraded, and its large model had been officially commercialized.

The large model’s version code name was—WD 1.0!

This patient was undergoing a laparoscopic partial hepatectomy for a liver tumor. After administering epidural anesthesia combined with tracheal intubation, the team proceeded.

They used the most suitable five-port method on the patient to establish pneumoperitoneum. The brand-new commercial version of the ultrasound equipment, fluorescence lens, HD camera, and high-definition imaging and display system all started running simultaneously.

The entire equipment system was a first-generation, brand-new product designed by Wu’s Pharmaceutical Company and manufactured by Jin Pharmaceutical Group!

Supported by the commercial version of the WD 1.0 large model and its massive database, the official surgery commenced.

According to the design from Wu Ting’s R&D team, the commercial version of the large model and its database had both online and offline modes.

Every surgical operation, video, and piece of data would be uploaded to the cloud and transmitted to the central database of Wu’s Pharmaceutical Company.

In other words, as the system was promoted and adopted more widely, more and more data would be integrated, allowing the large model to continuously optimize and upgrade itself.

The more this system was used, the more powerful and intelligent it would become!

On the screen, the system automatically located the tumor’s position and borders and automatically captured and displayed the tumor’s proximity to intrahepatic blood vessels and the biliary tract...

Soon, the calculations were complete, and the optimal hepatectomy line was automatically generated...

Dean Chen was finally using this system in his own operating room. The entire experience could be summed up in one word: Awesome!

Dean Chen also believed that with the assistance of this system, the skill level of liver tumor resections in the Hepatic Tumor Surgery department at Xianglin City Xuanshang University Affiliated Tumor Hospital would undergo a dramatic transformation!

And as the system was promoted and adopted by these top-tier hospitals, the entire field of liver tumor resection would witness an epoch-making revolution.

The intelligent auxiliary system was officially stepping onto the stage of history!

The surgery took one and a half times longer than a conventional procedure, but this was only its debut. Once the team became proficient, their efficiency would increase, the lesion resection rate would improve, and the overall success rate would take a qualitative leap!

Watching Dean Chen’s surgery, all the observing doctors were amazed and deeply envious.

After the surgery was completed, Dean Chen took everyone to the conference room for a debriefing and explanation.

Dean Chen’s team was undoubtedly the trendsetter in the field of hepatic tumor surgery in Xianglin City!

After the surgery, this system thoroughly captured the attention of department heads at various hospitals.

Subsequently, orders started pouring into Wu’s Pharmaceutical Company one after another!

Contracts were signed, deposits were paid, the factory went into operation, and training classes for surgical personnel were started ahead of schedule...

In a short period, this single commercial project brought in a huge influx of cash flow!

...

...

「The Hepatobiliary Surgery Department of Xiao City Jinggang University Affiliated First Hospital.」

On the operating table, the new laparoscopic Wu’s Umbilical Hole Skill was being fully implemented.

As a perfect cosmetic procedure, in addition to introducing the Wu’s Umbilical Knife, the lead surgeon also needed to master cosmetic suturing techniques.

Therefore, the Laparoscopic Diagnosis and Treatment Technology Research Center at City First Hospital had also launched relevant training programs: a course on using the Wu’s Umbilical Knife and a course on cosmetic suturing methods.

Riding this wave, the City First Hospital Research Center had thoroughly established its name and reputation among the surrounding hospitals.

The Wu’s Umbilical Hole Skill and the cosmetic appendectomy became classic techniques for laparoscopic appendectomies in Jin Province, even becoming standard clinical procedures.

Correspondingly, the Wu’s Umbilical Knife also became standard equipment in various hospitals.

As a marketing genius, Deng Feifei also launched a bundled cosmetic suture kit, which came pre-packaged with needles and thread.

This commercial project also had Wu’s Pharmaceutical Company earning a massive profit.

In addition to this, their other commercial projects, under the strategic planning of Deng Feifei and Wu Ting, were raking in money day after day.

The factory’s production lines also began operating around the clock.

...

...

「Weixing Petrochemical Conference Room」

Wu Ting paid a formal visit to the chief engineer and one of the company’s shareholders, Liang Kangjun, also known as President Liang.

Thanks to Wu Ting’s emergency treatment and subsequent care, President Liang had stopped taking Sorafenib, and his health had stabilized.

Today, Wu Ting had come to see President Liang to propose a business collaboration.

Wu Ting had already, through some maneuvering, completed the patent registration for a bioabsorbable intravascular stent.

Now, he wanted to collaborate with President Liang’s company, Weixing Petrochemical, to jointly produce the bioabsorbable polymer stent!